LINC02605

Across TCGA pan-cancer cohorts, LINC02605 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of LINC02605’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02605 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02605 is over-expressed in tumor, although a few such as LUSC and LUAD show the opposite, repressed pattern.

KIRC, LUSC, and LUAD are the cancer types where LINC02605 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02605 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	IV	+0.465	<.001	9	view →
LUSC	All	II,III,IV	−1.621	<.001	6	view →
LUAD	All	All	−0.661	<.001	5	view →
STAD	All	III,IV	+0.698	.005	4	view →
ESCA	All	All	+0.881	.012	2	view →
UCEC	All	All	−0.320	.046	2	view →
PRAD	All	All	+0.201	.018	2	view →
BRCA	All	III,IV	−0.122	.038	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

LINC02605–KIRC

Open the KIRC breakdown →